miR-214 can inhibit the development of hepatocellular carcinoma (HCC) by regulating the expression of zeste homologue 2 (EZH2), β-catenin (ctnb1), and E-cadherin (CDH1) [7]. This evidence concerns the gene EZH2 and hepatocellular carcinoma.